Colonova is a specialty pharmaceutical company that provides formulation development for companies who are looking for a more cost-effective solution for the oral administration of active ingredients in the colon or large intestine. Unlike other colon-specific technology platforms, Colonova's technology can be for the oral formulation of a wide range of active ingredients, from small molecules to biologics. Companies who can benefit from the formulation development focus on the fields of colon related diseases such as inflammatory bowel diseases, irritable bowel syndrome and colon cancer as well as companies in the clinical nutrition industry.